Chemicals for Pharmaceuticals & Healthcare in Malaysia
ChemTrade supplies chemicals for pharmaceuticals & healthcare in Malaysia. Each listing carries typical specifications, packing and availability.
| Product | Used for |
|---|---|
| 1,4-Dioxane | Used in controlled synthesis and process-development settings subject to the customer's technical requirements. |
| 1,5-Pentanediol | Used in controlled synthesis as a specialty intermediate where this defined diol is specified. |
| 2-Hydroxyethyl Methacrylate | Monomer named in dental composite, cement and acrylic prosthetic formulations and in hydrogel and contact-lens polymer chemistry. What a given formulation may use is decided by its own specification and documentation. |
| 2-Methylimidazole | Used as a heterocyclic building block in controlled fine-chemical and pharmaceutical synthesis. |
| 2-Methylpentane | May be used in controlled process or extraction work where the solvent specification is approved by the buyer. |
| 5-HTP | Nutraceutical and supplement manufacturers use purified, extract-derived or carrier-based 5-HTP ingredients in capsules, tablets, sachets and powder blends. Ingredient basis, carrier and dosage-form requirements should be stated. |
| Acai | Raw powder or extract ingredient for nutraceutical and supplement formulations that define botanical identity, composition, carrier and quality requirements, without implying a health or finished-product efficacy claim. |
| Acesulfame Potassium | Sweetening and taste-masking in selected oral liquids, chewable and effervescent dosage forms, nutraceutical powders and dietary supplements when the required grade and documentation are specified. |
| Acetal | Synthesis and development input for processes that specify acetal by CAS 105-57-7, with the required assay, water, acidity, impurity and documentation criteria stated by the manufacturer. This is not a finished medicine. |
| Acetic Acid | Intermediate and process acid in selected pharmaceutical and antiseptic formulations, subject to the required grade and documentation. |
| Acetic Anhydride | Acetylating reagent and intermediate in suitable pharmaceutical synthesis routes made to a buyer-defined grade. Supply is subject to applicable requirements. |
| Acetonitrile | Reaction and recrystallisation solvent in active ingredient and fine-chemical routes, and the mobile-phase solvent behind release and stability testing in quality control laboratories. |
| Acetyl Tributyl Citrate | Plasticiser for film and enteric coatings on pharmaceutical dosage forms where the manufacturer specifies ATBC identity and assay. |
| Acetylacetone | Building block in heterocyclic synthesis, where the 1,3-diketone reacts with amines, hydrazines and ureas to form pyrazoles, pyrimidines and related rings used in intermediate manufacture. |
| Acetylsalicylic Acid | Research and formulation-development work where the buyer controls purity, impurity and process requirements for the raw material. |
| Activated Carbon | Process purification and decolourisation of intermediates and process streams where residual colour or organic impurities must be reduced. |
| Adenine | Nutraceutical and specialty formulation development where identity, purity and dosage-form compatibility are evaluated by the buyer. |
| Adenosine | Nutraceutical and specialty-product development under buyer-defined raw-material and dosage-form requirements. |
| Agar Agar | Gelling and suspending aid in suitable pharmaceutical gels and related formulations, subject to the selected grade and specification. |
| Agarose | Life-science research, process development and biomolecule separation work where an agarose grade is selected against a defined protocol and purity requirement. |
| Alfalfa | Botanical raw material for nutraceutical and supplement manufacturers that process alfalfa leaf, powder or extract under their own finished-product specifications, without implying health efficacy for the ingredient. |
| Alginic Acid | Binder, suspending aid and formulation component in selected tablet, liquid and topical systems where the acid polymer and the required excipient-grade specification are defined by the manufacturer. |
| Allantoin | Ingredient in selected topical pharmaceutical and related formulations where pharmaceutical-grade material and matching documentation are specified. |
| Allulose | Sweetening component in selected lozenges, chewable products and related formulations where the buyer specifies a food or formulation grade of allulose. Supply is subject to applicable requirements. |
| Almond Oil | Lipid carrier or ointment-base component in suitable formulations that require a separately qualified application grade and defined oxidation and impurity limits. |
| Alpha-Cyclodextrin | Complexing, carrier and solubilisation aid for pharmaceutical and nutraceutical development where molecular compatibility and the required excipient specification have been established by the formulator. |
| Alpha-Tocopherol | Supplement and healthcare formulators use alpha-tocopherol in oil-based liquids, softgels and other preparations where identity, assay, carrier compatibility and oxidation control are defined by the formulation. |
| Aluminium Chloride | Catalyst and process reagent in selected pharmaceutical-intermediate and fine-chemical syntheses, with grade and impurity controls matched to the process specification. |
| Amaranth | Colour input for selected nutraceutical tablets, capsules, coatings, syrups and supplement formats where the formulation explicitly names Amaranth CI 16185. Supply is subject to applicable requirements. |
| Amla | Bulk whole-fruit powder for selected nutraceutical powders, capsules and tablets manufactured against a defined botanical and ingredient specification, without making a finished-product health claim. |
| Ammonium Iodide | Ingredient for dietary supplement and nutraceutical formulations where the formulator names ammonium iodide and its acceptance specification. |
| Ammonium Nitrate | Instant cold packs, which work because dissolving the salt absorbs heat from its surroundings. A small volume beside the fertiliser and mining trades. |
| Amylase | Digestive-enzyme and nutraceutical formulations using a grade with stated activity, carrier and microbiological controls. |
| Aniline | Synthesis intermediate for selected pharmaceutical and specialty molecules. Buyers should state the purity, water and related-substance limits for the manufacturing step. |
| Anthocyanins | Bulk pigment or botanical fraction for selected nutraceutical powders, capsules and tablets made to a source and composition specification, without implying a health effect. |
| Antifoam | Foam control in fermentation, bioprocess vessels, liquid manufacture and filling where the selected grade matches the buyer's process specification. |
| Apigenin | Healthcare-product developers evaluate purified or prepared apigenin grades for formulation and analytical work, with identity, purity, particle behaviour and supporting documents set by the product specification. |
| Apocynin | Bulk ingredient for selected nutraceutical and pharmaceutical research or formulation, without assigning a health outcome to the raw material. |
| Apple Cider Vinegar | Liquid or powder ingredient in specified dietary-supplement and nutraceutical formulations where the vinegar basis, carrier system and required documents are defined. Supply is subject to applicable requirements. |
| Arabic Gum | Binder, suspending aid, emulsifier and film-forming excipient in tablets, syrups and other formulated products, subject to the selected grade and specification. |
| Arachidonic Acid | Raw material for nutraceutical, supplement and specialist pharmaceutical formulation under the buyer's identity, composition and finished-product controls, without implying health efficacy for the supplied ingredient. |
| Arbutin | Raw material in selected nutraceutical and pharmaceutical formulations that require a defined Arbutin anomer, purity basis and related-substance profile. This page makes no therapeutic, prevention or efficacy claim. |
| Ascorbic Acid | Active ingredient or excipient in vitamin C preparations, oral solids, sachets and liquid formulations, selected against the required pharmacopoeial or buyer specification. |
| Ashwagandha | Used as a root, powder or extract ingredient in supplement and nutraceutical manufacturing with buyer-defined plant-part, extract and carrier specifications. |
| Asiaticoside | Bulk ingredient for selected nutraceutical and pharmaceutical formulation against a defined identity and purity, without a finished-product health claim. |
| Aspartame | Sweetening and taste-masking ingredient in suitable oral preparations, chewable products and related formulations made to the required grade. |
| Astaxanthin | Formulation ingredient for capsules, softgels and nutraceutical products where potency, source, carrier and documentation are defined by the buyer. |
| Baicalein | Raw material in specified formulation research or manufacture, supplied by chemical identity and analytical profile without a therapeutic claim. |
| Baicalin | Flavonoid ingredient for nutraceutical and herbal supplement formulations where the formulator names baicalin and its acceptance specification. |
| Bee Venom | Healthcare and nutraceutical product developers evaluate specified bee-venom raw materials in research and formulation work, with no assumption that the ingredient itself establishes finished-product performance or suitability. |
| Beeswax | Excipient and ointment base component in suitable pharmaceutical and topical formulations, subject to the selected grade and specification. |
| Benzaldehyde | Fine-chemical intermediate and formulation input where the process calls for benzaldehyde identity, assay and controlled related substances. |
| Benzalkonium Chloride | Antimicrobial raw material for antiseptic, sanitiser and wipe formulations where benzalkonium chloride is listed on the bill of materials. |
| Benzoic Acid | Pharmaceutical-grade free acid for selected formulations and compounding when the grade and specification match the product requirement. |
| Benzoyl Chloride | Intermediate for buyer-specified pharmaceutical and fine-chemical synthesis routes. |
| Benzyl Alcohol | Solvent and preservative in injectables, topical preparations and other formulated medicinal products, subject to the selected grade and specification. |
| Benzyl Benzoate | Excipient and solvent in formulated pharmaceutical products where the selected grade and product specification call for benzyl benzoate. |
| Beta Sitosterol | Raw ingredient for nutraceutical capsules, tablets and sachets without implying a therapeutic outcome. |
| Beta-Alanine | Raw material and intermediate in pharmaceutical, biochemical and controlled formulation processes requiring beta-alanine identity and defined impurity limits. Supply is subject to applicable requirements. |
| Beta-Carotene | Supplement and nutraceutical manufacturers use beta-carotene in beadlets, powders and oil dispersions for tablets, capsules, softgels and premixes that specify active content, source and supporting documents. |
| Beta-Cyclodextrin | Complexing and solubilisation aid in pharmaceutical and nutraceutical formulation work, with grade, purity and document requirements defined by the product developer. |
| Beta-Glucan | Yeast, cereal or fungal beta-glucan ingredients for nutraceutical and dietary supplement manufacturing, with the formulator selecting the source and structural specification. |
| Betaine | Formulation ingredient or methyl-donor component matched to the buyer's grade and documentation requirement; supply is subject to applicable requirements. |
| Betaine Hydrochloride | Raw material for tablets, capsules and sachets purchased against a defined grade, assay and documentation requirement. |
| Betulinic Acid | Raw ingredient for nutraceutical formulation and development where betulinic acid identity and purity are specified without therapeutic claims. |
| Bilberry Extract | Raw ingredient for nutraceutical capsules, tablets and sachets without implying a health or therapeutic outcome. |
| Biotin | Bulk ingredient for supplement, nutraceutical and pharmaceutical manufacturing, supplied as pure D-biotin or a declared trituration rather than as a finished tablet or capsule. |
| Bisabolol | Raw ingredient for selected nutraceutical and topical formulation development without therapeutic claims. |
| Blueberry | Blueberry powders and defined extracts as botanical or nutritional raw materials for supplement formulations, selected by composition and quality specification without implying a finished-product health claim. |
| Borage Oil | Bulk borage oil or declared carrier powder for nutraceutical and dietary supplement manufacturing, with the formulator defining fatty-acid profile, oxidation controls and excipient requirements. |
| Brilliant Blue FCF | Colouring for pharmaceutical and nutraceutical coating formulations where Brilliant Blue FCF is specified. |
| Bromelain | Raw material for nutraceutical, supplement and specialty ingredient producers that formulate bromelain by source, activity method, carrier and quality specification, without implying finished-product health efficacy. |
| Bromhexine Hydrochloride | Active raw material for oral liquid, tablet, capsule and sachet manufacture, bought against a named raw-material specification by generic and contract formulators. Supply is subject to applicable requirements. |
| Bromine | Reactive intermediate for pharmaceutical and fine-chemical synthesis where elemental bromine is named in the process and the required purity profile is defined. |
| Burdock Root Extract | Raw ingredient for nutraceutical capsules, tablets and sachets without health or therapeutic claims. |
| Butyl Rubber | Vial stoppers, plungers and closure compounds use halobutyl grades for low moisture and gas transmission and for clean extractable behaviour. State the pharmacopoeial requirement with the enquiry. |
| Butylamine | Considered as a process intermediate where the required purity and impurity limits are defined by the buyer. |
| Caffeic Acid | Raw material for nutraceutical and supplement formulation under the buyer's identity and finished-product controls, without implying health efficacy. |
| Caffeine | Active or formulation ingredient for tablets, capsules and combination products that specify caffeine anhydrous. Supply is subject to applicable requirements. |
| Calcium Ascorbate | Raw ingredient for nutraceutical tablets, capsules, powders and premixes under the buyer's formulation and finished-product specification. |
| Calcium Carbonate | Pharmaceutical-grade powder for selected formulation and excipient duties when the grade, purity and documentation set match the product requirement. |
| Calcium Caseinate | Raw material for nutritional powders, tablets, capsules and other formulated products that name calcium caseinate and control its composition and quality, without implying a finished-product health or performance claim. |
| Calcium Citrate | Raw material for tablets, capsules, sachets and other pharmaceutical or nutraceutical formulations that specify calcium citrate against a stated monograph or buyer quality standard. |
| Calcium Lactate | Calcium source or mineral component in oral solids, sachets, syrups and other formulated products, selected against the required pharmacopoeial or buyer specification. |
| Calcium Stearate | Tablet lubricant, glidant and anticaking agent in solid dose manufacture where a pharmaceutical grade calcium stearate is specified. |
| Calcium-D-Pantothenate | Raw material for supplement, nutraceutical and pharmaceutical formulation where the manufacturer specifies the D-pantothenate calcium salt rather than pantothenic acid, panthenol or a finished dosage product. |
| Camphor | Pharmaceutical or compounding grade material for selected formulations where solid camphor is specified, subject to the grade and documentation required. Supply is subject to applicable requirements. |
| Cannabinoids | Nutraceutical and specialty formulators may assess isolates, extracts, distillates or powders as raw-material inputs. Composition, dosage form, carrier and supporting-document requirements should be provided with the enquiry. |
| Capsaicin | Pharmaceutical-development and active-ingredient formulation work where the buyer specifies capsaicin identity, assay and applicable product requirements. |
| Carbomer | Thickener and suspending agent in topical gels, ointment bases, oral suspensions and mucoadhesive systems. Suitability rests on the grade specification and the finished dosage form, so describe the end use. |
| Carboxymethyl Cellulose | Tablet binder and viscosity modifier in suspensions and syrups. |
| Carmine | Colour raw material for nutraceutical and specialist formulation under the buyer's composition and finished-product controls. |
| Carnauba Wax | Tablet coating, polishing and film-forming aid in selected solid-dose formulations, subject to the grade and specification requested. |
| Carnosic Acid | Ingredient for nutraceutical formulation under the buyer's content, impurity, particle and finished-product requirements, without implying health efficacy. |
| Carnosine | L-carnosine raw material for dietary-supplement and nutraceutical formulation, selected by identity, method-specific assay, purity profile, physical form and declared carrier rather than by a finished-product claim. |
| Carrageenan | Suspending and viscosity agent in oral liquid preparations, and a gelling component in capsule and topical systems, subject to the grade selected. |
| Carvacrol | Nutraceutical and specialist formulation work that names carvacrol as an ingredient and sets the required purity, related-substance and documentation specification without implying a therapeutic outcome. |
| Carvone | Raw material for qualified nutraceutical and specialist formulation under the buyer's identity, composition and finished-product controls. |
| Castor Oil | Excipient and carrier in oral and topical preparations, and the raw material the ethoxylated solubilisers are made from. |
| Castor Oil Ethoxylate 45 | Formulation solubiliser or emulsifier when a buyer specification names PEG-45 castor oil or castor oil ethoxylate 45 EO for a liquid system. |
| Cayenne Pepper Powder | Botanical raw material for nutraceutical powders, capsules and tablets under the buyer's identity and finished-product controls, without implying health efficacy. |
| Cellulose Acetate | Used in selected film-coating, membrane and controlled-release applications where the polymer grade and documentation requirements are defined. |
| Ceteareth-60 Myristyl Glycol | Nonionic co-emulsifier and consistency aid in topical bases, where an ethoxylated structuring ingredient is written into the formulation. |
| Cetearyl Alcohol | Fatty alcohol component in ointments, creams and topical bases where an excipient-grade cetearyl or cetostearyl alcohol is specified. Suitability depends on the selected grade and target monograph or internal standard. |
| Cetrimide | Raw-material input for topical cleansing and antiseptic formulations where cetrimide is named in the formulation and the required composition and test basis are stated by the manufacturer. |
| Cetyl Alcohol | Fatty alcohol component in ointment bases and other pharmaceutical or excipient systems when the selected grade and documentation match the formulation requirement. Supply is subject to applicable requirements. |
| Cetylpyridinium Chloride | Quaternary raw material for topical and healthcare product formulations that name cetylpyridinium chloride in the specification. |
| Chitin | Application-qualified biopolymer raw material in pharmaceutical, biomedical and controlled formulation development where source and purity are defined. Supply is subject to applicable requirements. |
| Chlorella | Raw material for nutraceutical and dietary-supplement capsules, tablets, sachets and powder blends, supplied against the formulator's identity, microbiological and contaminant requirements without finished-product health claims. |
| Chlorhexidine Gluconate | Cationic bisbiguanide for clinical antiseptic solutions, surgical scrub bases and other pharmaceutical preparations where a suitable grade and concentration are specified. |
| Chlorocresol | Topical and pharmaceutical preservation where chlorocresol is specified and the required grade is suitable for the formulation. |
| Chloroform | Process solvent in pharmaceutical intermediate and active-ingredient manufacture where the chemistry calls for chloroform at a stated purity or stabiliser level. |
| Chlorophyll | Raw pigment ingredient in selected nutraceutical and pharmaceutical formulations that require a defined biological source, chlorophyll a and b profile, content basis and impurity controls. This page makes no health or therapeutic claim. |
| Chloroxylenol | Antiseptic ingredient for topical antiseptic solutions, wound-cleaning preparations and related pharmaceutical formulations, subject to the selected grade and specification. |
| Cholesterol | Lipid and liposomal formulations, pharmaceutical development and selected diagnostic or biochemical preparations that specify cholesterol with a defined purity, source and impurity profile. |
| Choline Bitartrate | Choline source in nutraceutical and dietary supplement formulations, including tablets, capsules and powder blends. |
| Chondroitin Sulphate | Active or excipient material for joint health nutraceuticals, supplements and related oral formulations. |
| Chrysin | Flavone ingredient for dietary supplement and nutraceutical formulations with the assay and documentation required by the finished product. |
| Chymotrypsin | Proteolytic enzyme ingredient in oral enzyme formulations and supplement-led product lines. |
| Cinnamaldehyde | Aroma ingredient or synthesis intermediate for pharmaceutical and fine- chemical formulations where identity, purity and documentation are defined by the approved process. Supply is subject to applicable requirements. |
| Cinnamon | Botanical and nutraceutical manufacturers use declared cinnamon bark grades as a raw material for controlled processing, with species, plant part, cleanliness and supporting ingredient documents defined before production. |
| Cinnamon Oil | Flavour or aroma component in selected formulated pharmaceutical products where the buyer specifies a suitable grade, identity and compositional profile rather than relying on a general cinnamon name. |
| Citric Acid | Anhydrous grade for effervescent tablets and powders, pH adjustment and chelation where free moisture from monohydrate would shorten shelf life or start premature reaction with carbonates. |
| Citric Acid Monohydrate | Acidulant or pH-adjusting excipient in syrups, solutions and other formulations that accept monohydrate crystal water, subject to the selected grade and specification. |
| Clotrimazole | Active ingredient for antifungal creams, lotions, solutions, powders and other dosage forms where clotrimazole is named in the manufacturing specification. The required grade and particle-size profile depend on the formulation and process. |
| Cocoa Butter | Lipid base or formulation component in selected topical and solid preparations where an appropriate cocoa butter grade and raw-material specification are defined by the manufacturer. |
| Coconut Oil | Carrier, base or formulation oil in selected pharmaceutical and nutraceutical products that specify coconut oil or a defined fraction. Grade, specification and documentation requirements should accompany the enquiry. |
| Coenzyme Q10 | Raw ingredient for nutraceutical capsules, tablets, softgels, sachets and powder blends. Buyers specify ubiquinone or ubiquinol, active content, carrier system and the approval parameters for the finished formulation. |
| Collagen | Collagen peptide ingredient for dietary-supplement and nutraceutical powders, capsules or tablets, with source, protein profile and documentation matched to the finished-product brief. |
| Colostrum | Raw ingredient for capsules, tablets, sachets and other supplement formulations where the recipe specifies the Colostrum form and composition, without implying a therapeutic or finished-product efficacy claim. |
| Conjugated Linoleic Acid | Supplement manufacturers use application-qualified CLA oils and powder preparations in softgels, capsules, tablets and sachets. The required form, total CLA content, isomer profile, carrier and documentation should be stated. |
| Coriander Oil | Aroma or flavour component in selected pharmaceutical formulations where the buyer specifies the botanical identity and compositional profile. |
| Corn Oil | Lipid carrier, emollient or ointment-base component in selected pharmaceutical and nutraceutical formulations when the required identity, purity and documentation controls are stated. |
| Corn Starch | Binder, diluent and dry-blend aid in tablets and powder formulations when a pharmaceutical or food-suitable grade and specification are selected. |
| Cotton | Application-qualified absorbent cotton fibre for medical and healthcare converting where cleanliness, absorbency and required documentation are specified. Supply is subject to applicable requirements. |
| Cottonseed Oil | Lipid carrier or ointment-base component in pharmaceutical and nutraceutical formulations where the buyer specifies grade, physical form and supporting documentation. |
| Cranberry | Defined cranberry powders and extracts as raw materials for supplement manufacturing, selected by starting material, carrier and compositional specification without making a finished-product health claim. |
| Cream of Tartar | Pharmaceutical-grade monopotassium tartrate for excipient use and effervescent formulations where the salt, not free tartaric acid, is specified. Supply is subject to applicable requirements. |
| Creatine Monohydrate | Raw ingredient for capsules, tablets, sachets and other nutraceutical formulations that require Creatine monohydrate identity, quality limits and documentation against the buyer's own specification. |
| Croscarmellose Sodium | Disintegrant for tablets and capsules in oral solid dosage manufacture, selected for rapid water uptake and tablet breakup. |
| Crospovidone | Superdisintegrant in immediate-release tablets and hard capsules, used at low inclusion levels to break the compact apart quickly and release the active for dissolution. |
| Crotonaldehyde | Fine-chemical and pharmaceutical-process developers may evaluate crotonaldehyde as a synthesis intermediate, with identity, impurity profile and grade controlled by the buyer's process specification. |
| Curcumin | Raw material for nutraceutical and supplement manufacture in powders, capsules, tablets and other finished forms under the buyer's identity, composition and process controls, without implying health efficacy. |
| Cyanamide | Intermediate for active pharmaceutical ingredient synthesis where a defined cyanamide source is specified. |
| Cyclodextrin | Pharmaceutical and nutraceutical developers use type-specific cyclodextrins as formulation excipients in controlled complexation and solubility work, with identity, grade and supporting documents set by the formulation. |
| Cyclohexanone | Reaction and recovery solvent, and a starting material for ring-substituted intermediates where the ketone carbonyl is the reactive site. |
| Cyclopentanone | Synthesis building block for pharmaceutical intermediates where assay and impurity limits are defined in the buyer specification. |
| D-Mannose | Bulk nutraceutical ingredient for contract manufacture of capsules, tablets, sachets and powder blends. This page covers the raw D-mannose input rather than a finished consumer supplement or any therapeutic claim. |
| D-Ribose | Pure D-ribose raw material for dietary-supplement and nutraceutical production, selected against method-specific assay, related-sugar, moisture and microbiological specifications without making a health claim. |
| Dandelion Extract | Nutraceutical and botanical-raw-material buyers assess dandelion extract by species identity, plant part, extract ratio, carrier, microbiological controls and required documentation without treating it as a finished therapeutic product. |
| Denatured Alcohol | Solvent in selected medicinal solutions, tinctures and topical preparations where the chosen denatured grade and specification meet the formulation requirement. Supply is subject to applicable requirements. |
| Deoxycholic Acid | Pharmaceutical and fine-chemical development teams may evaluate deoxycholic acid as a raw material, analytical substance or synthesis input under their own quality and process controls. |
| Dextrin | Binder, carrier or formulation aid in selected pharmaceutical and nutraceutical products when the source, grade and quality controls match the written specification. |
| Diborane | Reducing agent in selected API and intermediate syntheses where the buyer specifies diborane as the boron reagent. |
| Dibutyl Ether | Extraction, washing and synthesis solvent in pharmaceutical intermediate processes where the approved route names di-n-butyl ether. |
| Dibutyl Sebacate | Excipient plasticiser for specified tablet or capsule coating systems, subject to the formulation standard and impurity profile supplied by the buyer. |
| Dicalcium Phosphate | Diluent and compressible filler or binder in tablets, capsules and other dry-dose forms, subject to the selected pharmaceutical or excipient grade. |
| Diethyl Carbonate | Process reagent for pharmaceutical and fine-chemical routes that explicitly specify DEC. Enquiries should include the route's assay and impurity needs. |
| Diethyl Ether | Reaction medium for moisture-sensitive synthesis steps and a washing or recrystallisation solvent in active ingredient routes, using dried material where the chemistry demands it. |
| Diethyl Sebacate | Specialty formulation or synthesis input subject to the buyer defining the grade, compendial expectations and intended use. |
| Diethyl Sulfate | Intermediate for qualified pharmaceutical and fine-chemical synthesis where the process owner defines purity and impurity requirements. |
| Diethylamine | Building block and process intermediate in selected pharmaceutical and fine chemical synthesis routes that call for this secondary aliphatic amine. |
| Diethylene Glycol Monoethyl Ether | Solubilising and carrier solvent in liquid, topical and laboratory preparations where a water-miscible, high-boiling ether is written into the formulation, with the purity level set by the buyer's own standard. |
| Dihydromyricetin | Purified botanical raw material in suitable nutraceutical powders, capsules, tablets and premixes that specify assay method, source route, particle size and carrier content without relying on a health claim. |
| Diisononyl Cyclohexane-1,2-Dicarboxylate | Plasticised healthcare-related polymer components where the manufacturer has selected and validated DINCH for the intended formulation and use. |
| Diltiazem HCl | Active pharmaceutical ingredient for cardiovascular dosage form manufacture where the buyer specifies the required standard and impurity profile. |
| Dimethyl Isosorbide | Solvent and vehicle for topical and selected pharmaceutical formulations where the buyer specifies purity and impurity limits. |
| Dimethyl Oxalate | Building block for selected pharmaceutical and fine-chemical routes where purity and impurity profiles are tightly specified. |
| Dimethyl Sulfoxide | Polar aprotic solvent and process medium in pharmaceutical synthesis and formulation where dimethyl sulfoxide is specified for the chemistry or product system. |
| Dimethylacetamide | Reaction solvent and synthesis support for API and intermediate manufacture where a polar aprotic amide of defined purity is required. |
| Dimethylamine | Amine building block for pharmaceutical and fine-chemical synthesis where the approved process defines purity, water content and related-amine limits. Supply is subject to applicable requirements. |
| Dimethylformamide | Solvent and process medium in pharmaceutical intermediate and active ingredient manufacture where the process chemistry calls for DMF. |
| Diosgenin | Steroidal intermediate for hormone and corticosteroid synthesis routes where the buyer specifies diosgenin identity and assay. |
| Dipotassium Phosphate | Buffer component and potassium-phosphate nutrient salt in selected pharmaceutical and nutritional preparations against the required grade. |
| Dipropylene Triamine | Specialty synthesis intermediate where the process owner defines purity, impurity and documentation requirements. |
| Disodium Hydrogen Citrate | Buffer and pH adjuster in oral, liquid and effervescent pharmaceutical formulations where citrate buffering capacity stabilises the finished product. |
| Distilled Water | Non-injectable process, cleaning and formulation work where distilled water is requested. This page does not cover sterile water or water for injection; name any monograph or purity standard in the enquiry. |
| Docosahexaenoic Acid | Used in selected pharmaceutical and nutritional ingredient-development work where chemical form, source basis and quality parameters are stated explicitly. |
| Eicosapentaenoic Acid | High-purity EPA material is evaluated for pharmaceutical and analytical work against a defined identity, purity and oxidation specification. |
| Elderberry | Elderberry fruit powder and extract enquiries for nutritional and supplement formulations where species, plant part, carrier, marker basis and supporting documents are specified. No health outcome is implied. |
| Ellagic Acid | Botanical reference material and formulation ingredient in selected nutraceutical and pharmaceutical development work. |
| Emu Oil | Bulk oil input for nutraceutical and dietary-supplement formulation, including softgel and capsule-filling operations that define the required processing basis, composition controls and documents. |
| Ergothioneine | Raw material for nutraceutical and dietary-supplement formulations that identify L-ergothioneine and define an appropriate ingredient specification. This page makes no therapeutic or health claim. |
| Erythritol | Sweetening or bulk component in lozenges, chewable products and other formulations where the buyer specifies a food or formulation grade of erythritol. |
| Ethanol | Solvent, extraction medium and processing aid in pharmaceutical and nutraceutical manufacture, subject to the selected grade and specification. |
| Ethyl Acetate | Crystallisation, washing and recovery solvent in active-ingredient manufacture, with the water and acidity limits set by the process rather than by the general solvent specification. |
| Ethyl Acetoacetate | Used in synthesis routes for selected pharmaceutical intermediates where the required purity and impurity profile are specified. |
| Ethyl Butyrate | Flavour and odour-masking input in suitable formulations where the buyer's product specification identifies ethyl butyrate and the required grade. |
| Ethyl Cellulose | Film former, binder and matrix polymer in tablet coatings, granulation, microencapsulation and controlled-release systems. Viscosity and substitution level are matched to the process and release design. |
| Ethyl Lactate | Process and cleaning solvent in pharmaceutical manufacturing where the grade, specification and documentation are defined by the buyer. |
| Ethyl Maltol | Flavour and aroma adjustment in oral and nutraceutical formulations where the buyer defines the required grade, sensory profile and documentation. |
| Ethyl Vanillin | Flavour and odour adjustment in suitable oral and nutraceutical formulations when the purchasing specification identifies ethyl vanillin and the required quality basis. |
| Ethylamine | Intermediate for qualified pharmaceutical and fine-chemical routes where the exact amine identity and concentration are specified. |
| Ethylene Oxide | Process material for validated industrial sterilisation systems that name ethylene oxide. This page does not cover steriliser equipment, treatment services or finished medical products. |
| Ethylenediamine | Synthesis intermediate where a short symmetrical diamine is required to form rings, salts or side chains in active ingredient and excipient manufacture. |
| Ethylethanolamine | Building block for pharmaceutical and fine-chemical synthesis subject to the process owner specifying purity and documents. |
| Ethylhexyl Palmitate | Considered for topical formulations where an emollient ester or carrier for oil-soluble ingredients is specified. |
| Eucalyptus Oil | Fragrance or cooling component in selected topical and formulated products when a pharmaceutical-standard or buyer-specified eucalyptus oil grade is required. Supply is subject to applicable requirements. |
| Eugenol | Ingredient or intermediate in suitable oral-care, dental and pharmaceutical formulation work that specifies eugenol identity and grade. Supply is subject to applicable requirements. |
| Evening Primrose Oil | Raw oil, concentrate or powder input for supplement and nutraceutical manufacturing. Finished softgels, capsules and retail preparations are separate products. |
| Ferric Ammonium Citrate | Raw material for specified nutrition and pharmaceutical-related formulations where identity, iron content, solubility and documentation requirements are established by the buyer. |
| Ferric Pyrophosphate | Iron source for oral supplement formulations where the buyer specifies ferric pyrophosphate, its assay and the required documentation. |
| Ferrous Fumarate | Iron ingredient for oral solid-dose products whose formula and release specification explicitly identify the fumarate salt. |
| Ferrous Gluconate | Water-soluble iron source for oral supplement liquids, tablets and capsules where ferrous gluconate is specified by assay and impurity limits. |
| Ferulic Acid | Raw material for nutraceutical and pharmaceutical formulation or development work that requires a declared ferulic acid identity, isomer profile, assay method and application-specific quality controls. This page makes no therapeutic or efficacy claim. |
| Fisetin | Material for formulation development and research programmes where fisetin is specified by assay and documentation requirement. |
| Fish Oil | Raw material for omega-3 and lipid formulations that require a declared fatty-acid profile, molecular form, oxidation limits and application-specific documentation. Supply is subject to applicable requirements. |
| Fluoride | Dietary-supplement and nutraceutical formulation where the approved product specification identifies the fluoride source, elemental basis, grade and required documentation. Supply is subject to applicable requirements. |
| Folic Acid | Active vitamin ingredient in tablets, capsules, powders and nutraceutical blends formulated to a defined folic-acid identity and quality specification. |
| Formamide | Reagent or process solvent in approved pharmaceutical intermediate routes where formamide identity and impurity limits are written into the process. |
| Fructose | Sweetening and bulk component in selected syrups, oral liquids and related formulations where pharmaceutical-grade D-fructose is specified. Supply is subject to applicable requirements. |
| Fucoidan | Source-defined or purified Fucoidan as a raw material for nutraceutical and dietary-supplement manufacturing, with identity, composition, molecular profile and quality criteria set by the manufacturer. |
| Fucoxanthin | Raw material for nutraceutical and supplement formulation, supplied against an ingredient specification rather than as a finished capsule or tablet. |
| Fumed Silica | Glidant and powder flow aid in tabletting and dry blending, and adsorption of small liquid additions onto a free-flowing powder, when a grade and documentation set suitable for the use are specified. |
| Galactose | Raw material for pharmaceutical, nutraceutical and specialist formulation work requiring a controlled D-galactose powder. |
| Gallic Acid | Purified raw material in suitable nutraceutical and pharmaceutical formulations that require an application-specific impurity and quality profile, without making a health or efficacy claim. |
| Gamma Butyrolactone | Intermediate and process solvent in pharmaceutical synthesis where the buyer specifies gamma-butyrolactone rather than a related pyrrolidone. |
| Gamma Cyclodextrin | Solubility and bioavailability enhancer for poorly soluble actives in pharmaceutical and nutraceutical formulations. |
| Gamma Oryzanol | Material for nutraceutical product development where the buyer specifies gamma oryzanol assay and documentation. |
| Gelatin | Capsule shells, tablet coating and suitable formulation work where source, Bloom strength, viscosity and a pharmaceutical specification are defined. |
| Ginger | Dried botanical raw material for nutraceutical and botanical-processing operations that define rhizome identity, moisture, foreign matter and required documentation. Supply is subject to applicable requirements. |
| Ginger Powder | Whole-ginger botanical powder for capsule, tablet, drink-powder and related nutraceutical formulations that specify ground rhizome rather than an extract. |
| Ginkgo Biloba | Botanical raw material for nutraceutical and supplement manufacturers that mill, extract or blend Ginkgo Biloba leaf under their own finished-product identity and quality controls, without implying health efficacy. |
| Glabridin | Material for nutraceutical and cosmeceutical product development where the buyer specifies glabridin assay and documentation. |
| Glucomannan | Raw material for capsules, tablets, sachets and nutritional formulations that specify purified Glucomannan of a declared source and quality grade, without implying a finished-product health claim. |
| Glucono Delta Lactone | Acidifying and chelating ingredient in selected pharmaceutical and nutraceutical preparations that name a mild lactone acid on the specification. Supply is subject to applicable requirements. |
| Glucosamine Sulphate | Raw material for nutraceutical tablets, capsules, sachets and combination products that identify glucosamine sulphate on the formulation. Grade, stabilising salt, particle form and documents should follow the finished product manufacturer's receiving specification. |
| Glucose | Excipient and sweetener in solid and liquid medicines, and carbohydrate source in oral rehydration and related preparations, subject to grade. |
| Glutathione | Healthcare-product developers specify reduced glutathione for tablets, capsules, powders and formulation work, with grade, purity basis, redox-form controls and supporting documents set by the product specification. |
| Glycerine | Humectant, solvent and lubricant in syrups, capsules and topical preparations, to the USP, EP or BP monograph. |
| Glycerol Monostearate | Emollient, emulsifier and viscosity-increasing agent in topical creams, ointments and related formulations when the selected grade is suitable. |
| Glycine | Amino acid raw material for tablets, capsules, injectables, medical nutrition and other formulated products when a pharmaceutical or nutrition-grade specification is required. |
| Glyoxylic Acid | Intermediate chemistry for selected pharmaceutical and fine-chemical routes. |
| Grape Seed Extract | Botanical raw material in nutraceutical powders, capsules, tablets and premixes where the formulator specifies the extract system, carrier and analytical marker without relying on a universal potency value. |
| Green Coffee Bean Extract | Ingredient for capsules, tablets, sachets and other nutraceutical formats where the manufacturer specifies botanical identity, extract ratio, chlorogenic-acid profile, caffeine limit, carriers and microbiological acceptance criteria. No finished-product health claim is implied. |
| Guar Gum | Binder, disintegrant and viscosity aid in tablets, suspensions and related dosage forms, subject to the selected grade and specification. |
| Gum Ghatti | Suitable grades are used as binders and suspension aids in pharmaceutical formulations, subject to the required specification. |
| Henna | Botanical raw material for selected nutraceutical or specialty formulations whose complete product specification explicitly calls for henna leaf powder. Supply is subject to applicable requirements. |
| Heparin | Source- and salt-defined bulk raw material for pharmaceutical manufacturing and formulation development. Finished injections, flushes and other dosage forms are separate products. |
| Hexamine | Supplied as methenamine or urotropine for selected antiseptic and disinfectant pharmaceutical preparations, subject to the required grade and documentation. |
| High Fructose Corn Syrup | Sweetener input for selected nutraceutical and liquid formulation work where the manufacturer defines the complete ingredient and finished-product specification. |
| Honey | Ingredient for nutraceutical preparations, lozenges, syrups and supplement formats where the product specification permits, without implying a therapeutic claim. |
| Honokiol | Research and formulation active where honokiol is specified for pharmaceutical development work. |
| Horseradish | Botanical and nutraceutical manufacturers evaluate declared horseradish-root powders or extracts as raw materials, with plant part, extract basis, carrier and supporting ingredient documents defined without making finished-product claims. |
| HPMC | Tablet binder, film coating polymer, sustained release matrix and the shell of vegetarian capsules. |
| Hyaluronic Acid | Topical formulation ingredient when a suitable grade is specified for non-injectable products; supply is subject to applicable requirements. |
| Hyaluronidase | Enzyme active for pharmaceutical formulation and development work where the buyer defines the grade and documentation requirement. |
| Hydrazine | Synthesis intermediate for selected pharmaceutical compounds. Buyers should state the required purity, impurity limits and documentation for the manufacturing step rather than treat it as a finished dosage ingredient. |
| Hydrazine Hydrate | Intermediate and reducing chemistry in pharmaceutical and fine-chemical manufacture where hydrazine hydrate is the named raw material, subject to the selected grade and specification. |
| Hydrogen Peroxide | Surface and equipment disinfection in manufacturing hygiene programmes where a peroxide solution is selected for the required strength and residue profile. |
| Hydrogenated Castor Oil | Lipid carrier, ointment-base and processing ingredient in specified pharmaceutical or nutraceutical formulations whose grade, purity and documentation are defined. Supply is subject to applicable requirements. |
| Hydroiodic Acid | Pharmaceutical and fine-chemical intermediate production where the route calls for hydroiodic acid at a defined assay, stabiliser basis and impurity profile. |
| Hydrolyzed Collagen | Bulk collagen peptide ingredient for nutraceutical powders, capsules and tablets manufactured against a written source, composition and document specification, without implying a finished-product health claim. |
| Hydrolyzed Keratin | Bulk protein hydrolysate for nutraceutical powders, capsules and tablets where the manufacturer defines source, physical form, composition and microbiological controls without treating it as a finished supplement. |
| Hydroxylamine Hydrochloride | Intermediate and reagent in selected pharmaceutical and fine-chemical synthesis, subject to the required purity and documentation. |
| Hydroxylamine Sulphate | Intermediate use in pharmaceutical and agrochemical synthesis where hydroxylamine sulphate is specified. |
| Hydroxypropyl Beta-Cyclodextrin | Excipient and formulation aid for solubilisation, complexation, stabilisation and carrier applications designed to a complete pharmaceutical specification. |
| Hydroxypropyl Cellulose | Application-qualified hydroxypropyl cellulose is used as a binder, film former, coating aid and viscosity-control excipient in tablets, granules and other formulated dosage systems. The viscosity grade and formulation process should be stated in the enquiry. |
| Hydroxytyrosol | Raw material in nutraceutical and pharmaceutical formulations that require a defined Hydroxytyrosol content, source or purity basis and related-substance profile. This page makes no therapeutic, prevention or efficacy claim. |
| Hyssop Oil | Ingredient for suitable nutraceutical preparations where botanical identity, constituent profile and document requirements are defined without implying a health outcome. |
| Imidazole | Intermediate for pharmaceutical synthesis rather than a finished dosage ingredient. Buyers should state purity, related-substance limits and the documentation required for their manufacturing process. |
| Indigo Carmine | Colouring component in selected tablet coatings, capsules, liquid medicines and nutraceutical preparations when the pharmaceutical or formulation grade matches the written specification. Supply is subject to applicable requirements. |
| Indole-3-Carbinol | Raw material for nutraceutical capsules, tablets and sachets selected by identity, purity, particle form and documentation without making a health claim. |
| Inositol | Ingredient for nutraceutical capsules, tablets, sachets and powdered supplements, with identity, assay and documentation matched to the finished product specification. |
| Invert Sugar | Nutraceutical and specialty-product formulators may specify invert sugar as a liquid formulation input where sugar profile, solids basis, source declaration and supporting documents are part of the approved raw-material requirement. |
| Iodine | Starting material for antiseptics, iodophors, organic iodides and other iodine-containing pharmaceutical intermediates, subject to the selected grade and specification. |
| Ion Exchange Resin | Purified water generation ahead of distillation or membrane stages, with the required specification and documentation stated in the enquiry. |
| Isomalt | Excipient in lozenges and chewable tablets where an approved formulation calls for isomalt and defines the necessary compendial, particle and microbiological controls. |
| Isomaltulose | Carbohydrate ingredient for dietary supplement and nutraceutical products that specify isomaltulose and its associated documentation. |
| Isopropyl Acetate | Process solvent for reactions, washing and liquid extraction in active-ingredient and fine-chemical manufacture, run to the plant's own specification. |
| Isopropyl Myristate | Solubilising and penetration vehicle in topical ointments, creams and related bases when an excipient-grade or monograph-aligned isopropyl myristate is specified. Suitability depends on the selected grade and target standard. |
| Isopropyl Palmitate | Vehicle and co-solvent in topical ointments, gels and medicated creams when the formulation calls for an excipient-grade ester. Suitability follows the grade selected and the standard the formulation is written to. |
| Isopropylamine | Building block in pharmaceutical and fine-chemical synthesis where the production route identifies isopropylamine and controls its impurity profile. |
| Itaconic Acid | Intermediate for selected synthesis routes where a suitable purity and documented grade are specified. Supply is subject to applicable requirements. |
| Juniper | Whole-berry powder or cut botanical material as a raw ingredient for nutraceutical and supplement manufacturing, selected by botanical identity, plant part and quality specification without making a health claim. |
| Kaempferol | Raw material for nutraceutical capsules, tablets and premixes selected by aglycone identity, purity, source and particle form without a health claim. |
| Karaya Gum | Binder and thickening component in selected supplement and healthcare formulations, including denture adhesive products. |
| Kelp | Bulk kelp powder for selected nutraceutical powders, capsules and tablets manufactured against a species, source, composition and contaminant specification, without making a finished-product health claim. |
| L-Alanine | Raw material for suitable pharmaceutical and nutraceutical formulations selected by chiral identity, assay, impurity profile and supporting documents. |
| L-Alanyl-L-Glutamine | Glutamine-source dipeptide for clinical nutrition and related pharmaceutical formulations where the buyer defines the approval specification. |
| L-Arginine | Raw material for pharmaceutical and nutraceutical manufacturing where the formulation calls for L-arginine base rather than a hydrochloride salt, derivative or finished supplement blend. |
| L-Aspartic Acid | Starting material and formulation ingredient for pharmaceutical and nutraceutical production that controls stereochemical identity, assay and impurities. |
| L-Carnitine | Ingredient for selected nutraceutical and nutritional formulations where the quoted grade and documents match the buyer's specification. Supply is subject to applicable requirements. |
| L-Citrulline | Raw material for nutraceutical capsules, tablets, sachets and powders selected by free-form L-citrulline identity and quality specification without a health claim. |
| L-Cysteine | Raw ingredient in pharmaceutical and nutraceutical formulations that require a defined L-isomer, purity and related-substance profile. This page makes no therapeutic or efficacy claim. |
| L-Glutamic Acid | Amino-acid ingredient or synthesis intermediate in pharmaceutical and nutraceutical formulation work that requires the L-isomer and defined impurity controls. Supply is subject to applicable requirements. |
| L-Glutamine | Raw material for nutraceutical and suitable pharmaceutical formulations selected by L-form identity, purity, particle form and supporting documents. |
| L-Histidine | Raw material and buffer component in suitable pharmaceutical or nutraceutical formulations selected by identity, impurity and solution controls. |
| L-Isoleucine | Raw material for suitable pharmaceutical and nutraceutical formulations selected by L-isomer identity, purity, particle form and documents. |
| L-Leucine | Pharmaceutical, nutraceutical, fermentation and cell-culture applications requiring a defined assay, optical identity and impurity profile. |
| L-Methionine | Raw material for pharmaceutical, nutritional, cell-culture and biochemical formulations that require L-isomer identity and application-specific impurity controls. Supply is subject to applicable requirements. |
| L-Proline | Raw material for pharmaceutical and nutraceutical formulations that require a defined L-amino acid identity, controlled purity and application-specific documentation. |
| L-Serine | Raw material for nutraceutical tablets, capsules and formulation development where L-isomer identity, purity and supporting documents are specified. This page makes no health or therapeutic claim. |
| L-Theanine | Raw material for supplement, nutraceutical and pharmaceutical formulation, supplied as an identified L-theanine ingredient rather than as a finished capsule, tablet or consumer blend. |
| L-Threonine | Amino acid ingredient for medical nutrition, dietary supplements and other formulated preparations where a defined L-threonine grade and specification are required. |
| L-Tryptophan | Ingredient in suitable pharmaceutical, clinical-nutrition and amino-acid formulations where the required monograph or product specification is stated by the buyer. |
| L-Tyrosine | Bulk ingredient for tablets, capsules and other specified preparations, released against the manufacturer's L-Tyrosine identity and purity criteria. |
| L-Valine | Defined amino acid input for pharmaceutical, medical-nutrition and nutraceutical formulations where the manufacturer controls purity, impurities and supporting documentation through its receiving specification. |
| Lactase | Ingredient for nutritional tablets, capsules, sachets and powder formulations that require a declared lactase activity and carrier system. No health claim is made. |
| Lactate Dehydrogenase | Raw material for clinical chemistry assays and diagnostic kit manufacture where the buyer specifies activity, source and stability documentation. |
| Lactitol | Active ingredient and excipient for pharmaceutical formulations, including oral preparations where the buyer specifies the hydrate form and documentation. |
| Lactobacillus Acidophilus | Raw culture ingredient for capsules, tablets, sachets and other supplement formulations that specify the exact strain, carrier, viability method and storage basis without a therapeutic or finished-product efficacy claim. |
| Lactoferrin | Lactoferrin raw material for dietary-supplement and nutraceutical formulation, selected by source, purity, method-specific assay, iron-saturation state and carrier composition without making a medical or finished-product efficacy claim. |
| Lactose | Diluent and carrier in tablets, capsules and dry-powder inhaler formulations, subject to the specified grade and documents. |
| Lactulose | Raw material for further manufacture of oral liquids, powders, tablets, capsules or sachets where the finished-product developer controls concentration, dosage, quality and performance without relying on this catalogue page for a therapeutic claim. |
| Lanolin | Ointment and cream vehicle for topical and dermatological preparations, on its own or blended with soft paraffin bases, when a grade meeting the formulation's pharmacopoeial specification is required. |
| Lemon Balm | Botanical raw material for nutraceutical and supplement manufacturing where the formulation identifies the herb, powder or extract form and its complete quality specification. This page does not cover finished dosage products. |
| Licorice | Raw material in nutraceutical and pharmaceutical formulations that require a defined Licorice species, plant part, extract basis and glycyrrhizin or other constituent profile. This page makes no therapeutic or efficacy claim. |
| Linolenic Acid | Nutraceutical oils, capsules and supplement formulations that call for alpha-linolenic acid with controlled identity, oxidation condition and documentation rather than a general botanical oil. |
| Lupeol | Triterpenoid material for formulation development and natural-product research where lupeol identity and purity are specified. |
| Lutein | Bulk nutraceutical raw material for capsules, tablets, sachets and softgel manufacture. The enquiry should identify free lutein, the preferred matrix and document requirements rather than a brand or a finished supplement. |
| Luteolin | Nutraceutical and supplement manufacturers use purified, extract-derived or carrier-based luteolin ingredients in capsules, tablets and powder blends. Content basis, carrier, dosage form and supporting-document needs should be stated. |
| Lycopene | Raw material in nutraceutical and pharmaceutical formulations that require a defined Lycopene source, content method, isomer profile and carrier system. This page makes no health, therapeutic or efficacy claim. |
| Lysine | Raw material in pharmaceutical and nutraceutical formulations that require a defined L-isomer, chemical form, assay and related-substance profile. This page makes no therapeutic or efficacy claim. |
| Lysozyme | Raw material for pharmaceutical and nutraceutical formulation or development work that specifies lysozyme or lysozyme chloride, activity basis, source and qualification criteria. No therapeutic claim is made. |
| MABS Resin | Selected healthcare or laboratory components where the polymer grade and end-use qualification are separately specified. |
| Maca | Nutraceutical and supplement manufacturers use maca root powder and defined extract grades in capsules, tablets and powder blends. Botanical source, processing basis, carrier and finished dosage-form needs should be stated. |
| Magnesium Ascorbyl Phosphate | Ascorbyl phosphate material for formulation development and research where the magnesium salt form is specified. |
| Magnesium Aspartate | Nutraceutical and healthcare-product manufacturers specify magnesium aspartate for tablets, capsules and powdered blends where the exact salt, magnesium contribution and supporting grade documents are defined. |
| Magnesium Carbonate | Antacid active and tablet excipient where acid-neutralising capacity, bulk and powder handling of the selected pharmaceutical grade matter. |
| Magnesium Citrate | Nutraceutical and supplement manufacturers use defined magnesium citrate powders and granules in tablets, capsules, sachets and powder blends. Hydration state, magnesium-content basis and dosage-form requirements should be stated. |
| Magnesium Gluconate | Pharmaceutical and nutraceutical producers use magnesium gluconate in tablets, capsules, powders and liquid formulations that define grade, hydration basis, magnesium content and supporting documents. |
| Magnesium Glycerophosphate | Used as a raw material in selected supplement and pharmaceutical manufacturing processes with an application-specific identity and quality specification. |
| Magnesium Glycinate | Raw material for selected nutraceutical and supplement formulations where the grade, magnesium basis and documentation meet the buyer's specification. Supply is subject to applicable requirements. |
| Magnesium Malate | Raw material for tablets, capsules, sachets and related mineral formulations matched to the required magnesium content, physical form and documentation. |
| Magnesium Oxide | Raw material for antacid and magnesium supplement manufacture, and an alkaline excipient in solid dose formulation. |
| Magnesium Stearate | Lubricant and anti-adherent in tablet compression and capsule filling, used at low addition levels in solid dose blends and in nutraceutical and supplement manufacture. |
| Malic Acid | Acidulant or pH-adjusting excipient in selected medicinal and nutraceutical products, subject to the required grade and specification. |
| Malonic Acid | Intermediate and development reagent for pharmaceutical and fine-chemical processes where malonic acid identity and a controlled impurity profile are written into the route. This is not a finished medicine. |
| Maltitol | Sweetener, vehicle and bulking component in oral syrups, chewable tablets, lozenges and similar formulations made to the grade and standard the buyer names. Supply is subject to applicable requirements. |
| Maltodextrin | Excipient for tableting, capsule filling, granulation and solid-dose carriers when a suitable pharmaceutical or pharmacopoeial grade is specified. |
| Mandelic Acid | Pharmaceutical and healthcare-product development may use mandelic acid as a synthesis or formulation input where the required grade, stereochemical basis and supporting documents are set by the buyer's specification. |
| Manganese Gluconate | Manganese gluconate ingredient for nutraceutical and dietary supplement manufacturing, with the formulator defining hydration, assay, elemental basis and excipient compatibility. |
| Mangiferin | Raw material for nutraceutical and pharmaceutical formulation or development work that requires a defined mangiferin identity, assay method and impurity profile. This page makes no therapeutic or efficacy claim. |
| Mannitol | Excipient, bulking agent and formulation aid in suitable tablets, capsules, powders and oral products made to the required compendial grade. |
| Matpers FD 297 | Solubilising and emulsifying aid in selected medicinal solutions and other formulated systems when the buyer names Matpers FD 297 or an equivalent castor oil ethoxylate grade. |
| Medium-Chain Triglycerides | Lipid carrier, formulation oil or powder input in pharmaceutical and nutraceutical development where chain profile, oxidation controls, excipient basis and documentation are defined. No therapeutic claim is made. |
| Menthol Crystal | Flavouring and counterirritant in cough syrups, lozenges, inhalant preparations and topical analgesic creams, subject to the selected grade and specification. |
| Mercury | Amalgam filling material in dental practice. |
| Methacrylic Acid | Monomer behind methacrylic acid copolymers used in dental and specialty resin systems. Suitability rests on the finished polymer specification, so describe the end use with the enquiry. |
| Methanesulfonic Acid | Intermediate and process acid in pharmaceutical and fine-chemical synthesis routes that specify methanesulfonic acid, subject to the selected grade and documentation. |
| Methoxypropylamine | Used as a synthesis intermediate where a specified methoxypropylamine grade is required. |
| Methyl Benzoate | Synthesis input for selected pharmaceutical and fine-chemical intermediates, ordered against the process-specific assay, water and impurity limits. |
| Methyl Cellulose | Binder and film-forming polymer for tablets and coatings, and the viscosity component in bulk-forming and ophthalmic formulations. State the grade and documentation needed with the enquiry. |
| Methyl Diethanolamine | Intermediate in selected pharmaceutical and agrochemical synthesis routes, subject to the selected grade and finished-product requirements. |
| Methyl Formate | Pharmaceutical and fine-chemical producers use suitable methyl formate grades in controlled synthesis where assay, impurity profile and reaction-related documentation must match the process specification. |
| Methyl Methacrylate | Monomer for selected dental materials and orthopaedic bone-cement systems where a defined grade and documentation set are required. Suitability depends on the finished formulation specification. |
| Methyl Paraben | Preservative raw material for oral liquids, syrups, suspensions and topical preparations where a pharmacopoeial designation is stated in the bill of materials. |
| Methyl Salicylate | Raw-material ester for topical analgesic rubs, balms and related medicated formulations. This page covers the industrial ester for manufacturing, not a finished consumer rub. Suitability depends on the selected grade and target specification. Supply is subject to applicable requirements. |
| Methylamine | Intermediate in the synthesis of active pharmaceutical ingredients and related amine building blocks. |
| Methylcyclohexane | Process solvent in pharmaceutical and specialty organic synthesis where methylcyclohexane is named in the process or cleaning step. |
| Methylene Chloride | Extraction and reaction solvent in pharmaceutical intermediate and active ingredient manufacture where the process chemistry calls for dichloromethane. |
| Microcrystalline Cellulose | The standard tablet and capsule excipient, working as diluent, dry binder and disintegration aid in a single addition. Grade code decides whether the route is wet granulation, roller compaction or direct compression. |
| Milk Protein | Raw material in selected nutraceutical and pharmaceutical formulations that specify a milk-protein family, source, composition and microbiological profile. This page makes no therapeutic, nutritional-performance or efficacy claim. |
| Milk Thistle Extract | Nutraceutical and dietary-supplement manufacturers use a source- and marker-profiled Milk thistle extract as a botanical raw material for tablets, capsules and powdered formats assessed against their complete product specification. |
| Modified Starch | Binder, diluent and disintegrant duty in solid-dose formulation, subject to the grade and documentation the buyer specifies for the application. |
| Mono Potassium Phosphate | Buffer component and mineral source in pharmaceutical and related formulations, subject to the selected grade and specification. |
| Monoammonium Phosphate | Buffer component and mineral source in pharmaceutical and related formulations, subject to the selected grade and specification. |
| Monocalcium Phosphate | Calcium phosphate source and excipient duty in dry-dose and oral formulations that specify the monobasic salt to a pharmacopoeial or equivalent grade. |
| Morpholine | Building block in pharmaceutical and fine-chemical synthesis where the morpholine ring is carried into the target molecule. |
| Mother of Pearl | Nutraceutical and healthcare-product formulation using a defined mother-of-pearl powder grade, without implying a health effect or treating natural nacre as interchangeable with purified mineral ingredients. |
| MSM | Raw material for nutraceutical capsules, tablets, sachets and powder blends, selected by identity, purity, particle form and documentation rather than by a medical or performance claim. |
| N-Acetyl-L-Cysteine | Formulation input for nutraceutical tablets, capsules, sachets and related dosage forms whose specification identifies N-Acetyl-L-Cysteine rather than free L-cysteine or a salt. This page makes no medical or health claim. |
| N-Butanol | Extraction and process solvent in pharmaceutical and fine chemical manufacture, against the grade and documentation named in the enquiry. |
| N-Butyl Bromide | Used as a butylating intermediate in pharmaceutical synthesis where the purchasing specification calls for n-butyl bromide or 1-bromobutane. |
| N-Heptane | Used as a reaction or crystallisation solvent in pharmaceutical and fine-chemical processing where the process specification calls for n-heptane. |
| N-Propanol | Process, granulation and cleaning solvent in pharmaceutical manufacturing, subject to the grade and documentation named in the enquiry. |
| Naringenin | Flavanone ingredient in nutraceutical and supplement formulations where a defined naringenin source is specified. |
| Natural Rubber | Dipped examination and related protective products when a suitable natural rubber latex grade and the buyer's required specification are identified. |
| Neotame | Sweetener and taste-system ingredient for selected oral solid and liquid formulations where purity, carrier, dosage form and supporting documents are specified by the formulator. |
| Nettle Extract | Botanical material for herbal preparations where a defined nettle extract source is required. |
| Niacin | Active or nutritional ingredient in pharmaceutical and nutraceutical preparations where the required identity is niacin rather than niacinamide. |
| Niacinamide | Raw material for pharmaceutical and nutraceutical products that require a defined niacinamide assay, impurity profile and application-specific documentation. |
| Nifedipine | Pharmaceutical manufacturers use application-qualified nifedipine API in solid-dose formulation after matching identity, assay, related-substance, particle and process requirements to the approved product specification. |
| Nitrogen | Controlled-atmosphere, blanketing and cryogenic processing applications where nitrogen form, quality and supporting documentation are specified by the buyer. |
| Nitromethane | Intermediate and reaction solvent in synthesis routes that build on the nitro group, including nitroalcohol chemistry and fine-chemical steps that require a high-purity nitromethane feed. |
| Nobiletin | Raw material for nutraceutical and supplement formulations that specify isolated nobiletin, a standardised citrus extract or a carrier-based preparation against a defined composition, without implying a health claim. |
| Nonoxynol-9 | Application-qualified nonoxynol-9 serves pharmaceutical and specialty-product manufacturing that defines the required monograph, impurity profile and supporting documents. |
| Octylamine | Speciality and pharmaceutical-intermediate chemistry where the exact amine identity is specified. |
| Oleic Acid | Excipient and process intermediate in selected drug, soft-gel and vitamin preparations, subject to the selected grade and specification. |
| Olive Leaf Extract | Raw material for nutraceutical and supplement manufacture where the buyer defines identity, assay and documentation requirements. |
| Olive Oil | Carrier and excipient oil in topical and oral preparations that call for an olive oil of a stated grade and specification. |
| Orange Oil | Flavour or aroma ingredient in selected pharmaceutical formulation work where sweet Orange oil is written into the raw-material specification. This page makes no therapeutic or efficacy claim. |
| P-Toluenesulphonic Acid | Intermediate and process acid in pharmaceutical and fine-chemical synthesis routes that name p-toluenesulphonic acid, subject to the selected grade and documentation. |
| Pancreatin | Multi-enzyme raw material for pharmaceutical and nutraceutical formulation. Buyers specify the source species, balance of protease, lipase and amylase activities, dosage-form process and required documents. Supply is subject to applicable requirements. |
| Panthenol | Ingredient in selected topical and formulated products where a panthenol grade is specified. Suitability depends on the selected grade and documentation requirement; supply is subject to applicable requirements. |
| Papain | Nutraceutical and digestive-enzyme formulations requiring a stated papain activity, carrier system and microbiological specification. |
| Paracetamol | Bulk API raw material for tablets, capsules, suspensions, suppositories, effervescent systems and related dosage forms under generic and contract manufacture. Supply is subject to applicable requirements. |
| Paraffin Wax | Ointment and suppository bases, and as a coating on tablets and capsules. |
| Paraformaldehyde | Intermediate and synthesis use in suitable pharmaceutical manufacturing routes, subject to the selected grade and specification. |
| Paraxanthine | Application-qualified raw material in controlled nutritional and pharmaceutical formulation work requiring paraxanthine identity, purity and documentation. Supply is subject to applicable requirements. |
| Peanut Oil | Refined peanut oil as a formulation vehicle or ointment-base component where the approved product specification names arachis oil and sets the required quality and documentation. Supply is subject to applicable requirements. |
| Pectin | Specified grades for selected oral and topical formulations as a gelling or stabilising aid, subject to the buyer's required pharmacopoeial or quality specification. |
| PEG-40 Hydrogenated Castor Oil | Formulation solubiliser for hydrophobic ingredients in oral, topical and other liquid systems when the buyer specifies polyoxyl 40 hydrogenated castor oil or a customer-defined standard. |
| Pentanal | Starting material or intermediate in selected pharmaceutical and fine-chemical synthesis, subject to the required purity and documentation. |
| Peppermint | Raw botanical material for nutraceutical and supplement manufacturers using dried leaf, cut herb or milled leaf powder under a defined identity and quality specification, without finished-product health claims. |
| Peppermint Oil | Excipient and flavouring oil in oral, topical and other formulated products where a pharmaceutical or pharmacopoeia grade of peppermint oil is required. Supply is subject to applicable requirements. |
| Pepsin | Bulk enzyme input for professional pharmaceutical or nutraceutical formulation, selected by source, proteolytic activity basis and document requirements. Supply is subject to applicable requirements. |
| Peracetic Acid | Surface, room and instrument disinfection duty in healthcare and laboratory settings where a peroxygen disinfectant is specified. |
| Petroleum Ether | Natural-product and active-ingredient extraction steps, and washing or precipitation stages that call for a defined petroleum ether fraction. |
| Petroleum Jelly | Ointment base and topical formulation ingredient where the required grade, purity profile and documentation are agreed before supply. |
| Phenol | Intermediate and synthesis feedstock in selected pharmaceutical and fine chemical routes, subject to the required grade and specification. |
| Phenolphthalein | QC laboratory titration and analytical reagent use where the selected grade and specification permit. Supply is subject to applicable requirements. |
| Phenoxyethanol | Solvent or preservative in selected topical preparations, vaccines and other formulated products, subject to the selected grade and specification. |
| Phenylacetic Acid | Fine-chemical and pharmaceutical manufacturers use suitable phenylacetic acid grades in controlled synthesis where identity, assay and impurity profile must match the reaction specification. |
| Phosphatidylcholine | Phospholipid excipient for emulsions, dispersions, lipid systems and liposome formulation work where the source, phospholipid profile, hydrogenation status and quality specification are controlled without implying therapeutic effect. |
| Phosphatidylserine | Bulk nutraceutical ingredient for capsule, tablet, sachet, powder-blend and softgel manufacture. Formulators specify source, assay, phospholipid profile, carrier and document requirements rather than relying on a finished-product claim. |
| Phosphorus Oxychloride | Standard chlorinating and dehydrating reagent in active ingredient and intermediate synthesis, including heterocyclic chlorination and formylation chemistry. |
| Phthalic Anhydride | Intermediate in selected synthesis routes; state the required purity and documentation with the enquiry. Supply is subject to applicable requirements. |
| Phycocyanin | Bulk nutraceutical ingredient for capsules and powdered formulations, selected by source, protein profile, purity criteria and document needs without implying a finished-product health claim. |
| Phytosterols | Ingredient in nutraceutical and dietary supplement formulations that specify a defined phytosterol composition. |
| Piperazine | Cyclic diamine building block for pharmaceutical and specialty-intermediate synthesis where the reaction specification identifies piperazine itself. |
| Piperidine | Piperidine serves as a heterocyclic building block and secondary amine reagent in the synthesis of pharmaceutical intermediates and piperidine-containing molecules. |
| Piperine | Bulk nutraceutical ingredient for capsules, tablets, sachets and powder blends, selected by piperine assay, botanical source, impurity profile and document requirements without implying a finished-product health claim. |
| Poloxamer 188 | Pharmaceutical and nutraceutical formulations that use Poloxamer 188 as a nonionic excipient for wetting, dispersion, emulsification, solubilisation or process stabilisation under the buyer's defined formulation specification. |
| Poloxamer 407 | Excipient for topical, oral and other pharmaceutical formulation work where Poloxamer 407 is selected against a named compendial or internal specification and validated in the complete dosage form. |
| Polydextrose | Bulking excipient, carrier and coating component in solid-dose work, where a soluble carbohydrate with little sweetness suits the formulation and the selected grade carries the documentation the buyer specifies. |
| Polyethylene Glycol | Ointment and suppository bases, tablet film coating, and as a solubiliser and excipient in liquid and solid dose formulation. |
| Polyethylene Oxide | Application-qualified polyethylene oxide grades are used in tablet matrices, binders and controlled formulation systems where molecular weight, viscosity, residual limits and supporting documents match the dosage-form requirement. |
| Polyphosphoric Acid | Intermediate and process aid in pharmaceutical and fine-chemical manufacture where a suitable purity grade is selected against the reaction and impurity profile. |
| Polysorbate 20 | Solubiliser and protein stabiliser in oral liquids, topical preparations and parenteral formulations against the NF or Ph. Eur. monograph. |
| Polysorbate 60 | Non-ionic emulsifier in topical creams, ointments and other formulations specified for Polysorbate 60, with the required standard stated by the buyer. |
| Polysorbate 80 | Solubilising and emulsifying excipient for oral liquids, topical preparations and other pharmaceutical formulations where the required grade and standard are specified. |
| Polyvinylpyrrolidone (PVP) | Povidone binder, granulation aid and film-forming polymer for professional pharmaceutical and nutraceutical formulation. Buyers specify K-value, residual monomer, moisture and documentation for the intended dosage-form process. Supply is subject to applicable requirements. |
| Pomegranate | Dried pomegranate arils as a botanical raw material in suitable nutraceutical and functional-food blends, without implying the composition or performance of an extract or finished supplement. |
| Potassium Acetate | Potassium source and buffering salt in formulation work, including dialysis and irrigation concentrate preparation, where the required standard is stated on the enquiry. |
| Potassium Bicarbonate | Electrolyte replenisher and systemic alkaliser in suitable pharmaceutical and nutraceutical formulations, subject to the selected grade and specification. |
| Potassium Carbonate | pH regulator and alkaline process chemical in selected pharmaceutical manufacture, subject to the selected grade and specification. |
| Potassium Chloride | Manufacturing input for oral rehydration salts, infusion and dialysis concentrate, and as an excipient. |
| Potassium Citrate | Buffering and pH control in oral and other formulated products when the selected grade meets the required monograph or finished-product specification. Supply is subject to applicable requirements. |
| Potassium Cocoyl Glycinate | Selected topical and healthcare cleansing formulations where the required grade, pH and supporting documentation are specified. |
| Potassium Cyanide | Process reagent for selected pharmaceutical-intermediate synthesis routes that specifically call for potassium cyanide. |
| Potassium Gluconate | Raw material for tablets, capsules, powders and liquid formulations where a pharmaceutical or nutraceutical potassium gluconate specification is required. |
| Potassium Iodate | Raw material for pharmaceutical and nutraceutical formulations requiring a controlled purity iodate grade. Enquiries should describe the formulation use and specification rather than a finished dosage requirement. |
| Potassium Iodide | Raw-material potassium iodide for pharmaceutical and related iodine formulations, subject to the selected grade and specification. Enquiries should describe formulation use rather than finished tablet or dosage requirements. |
| Potassium Sodium Tartrate | Used in selected effervescent and laxative formulations where the formulation calls for potassium sodium tartrate. |
| Potassium Sorbate | Used as an excipient preservative in selected oral and topical formulations when required by the product specification. |
| Potato Starch | Excipient, binder or disintegrant in tabletting and related solid-dose work when a suitable pharmaceutical or food-contact grade is requested. Supply is subject to applicable requirements. |
| Povidone Iodine | Bulk raw material for formulated antiseptic solutions, surgical scrubs, ointments, gargles and related pharmaceutical or OTC iodine complexes. Finished medicinal products are not supplied from this page. |
| Powdered Cellulose | Suitable Powdered Cellulose grades serve as binders, diluents, carriers and physical suspension-support ingredients in tablet, capsule, nutraceutical and powder formulations selected by particle, bulk and quality requirements. |
| Propiophenone | Aromatic ketone intermediate for pharmaceutical and fine-chemical synthesis where the process names propiophenone and its purity profile. |
| Propolis | Raw material for capsule, tablet, sachet and other supplement formulations where the recipe specifies the Propolis form and complete composition, without implying a therapeutic or finished-product efficacy claim. |
| Propyl Paraben | Preservative component in selected oral-liquid and topical formulations requiring propyl paraben. |
| Propylamine | Building-block and process reagent for pharmaceutical or healthcare-related synthesis where the exact propylamine identity is specified. |
| Propylene Glycol Dicaprylate/Dicaprate | Excipient component in selected topical formulations where a caprylic/capric ester of propylene glycol is specified. |
| Propylene Glycol USP | Solvent, cosolvent and humectant in oral, topical and other medicinal preparations where propylene glycol USP is named on the specification. |
| Protease | Defined protease raw materials for dietary-supplement and nutritional formulations, selected by exact enzyme identity, method-specific activity, carrier and blend composition without implying finished-product efficacy. |
| Protodioscin | Nutraceutical and supplement development work that specifies protodioscin as a defined marker or active substance with batch-level identity and assay. |
| Psyllium Husk | Bulk fibre ingredient for nutraceutical and pharmaceutical bulk-forming preparations, subject to the selected grade and specification. Supply is subject to applicable requirements. |
| Pullulan | Excipient for vegetarian capsule shells, tablet binding and oral-film formats where the grade and excipient documentation are specified. |
| Pyridine | Pharmaceutical and fine-chemical synthesis where pyridine is specified as a heterocyclic building block, solvent, base or reaction component under a defined assay and impurity profile. |
| Pyridoxine Hydrochloride | Bulk formulation input for nutraceutical and pharmaceutical manufacturing under a written identity, assay, impurity, particle and document specification, without a finished-product health claim. |
| Pyrrolidine | Cyclic amine building block for pharmaceutical and fine-chemical synthesis routes that specifically call for the pyrrolidine ring or pyrrolidine as a process reagent. |
| Pyrroloquinoline Quinone | Raw material for nutraceutical, supplement and specialist formulation under the buyer's identity and finished-product controls, without making health or therapeutic claims for PQQ. |
| Quercetin | Nutraceutical and supplement manufacturers use purified or formulated quercetin ingredients in capsules, tablets, powders and other preparations. Buyers should define the quercetin basis, carrier, dosage form and required quality documentation without treating the raw material as a finished supplement. |
| Quinine | Bulk formulation and research input under a written chemical-form, purity and impurity specification, without making a claim for the finished product. |
| Quinoline | Intermediate for active-pharmaceutical-ingredient and fine chemical synthesis routes built on the quinoline nucleus, with the purity profile defined by the buyer. |
| Raspberry Ketone | Bulk ingredient evaluation for nutraceutical or pharmaceutical formulation under a defined identity and quality specification, without a finished-product health claim. |
| Resveratrol | Raw material in nutraceutical and pharmaceutical formulations that require a defined Resveratrol isomer, content method, purity or extract basis and related-substance profile. This page makes no therapeutic or efficacy claim. |
| Retinol | Ingredient enquiries for selected oral or topical formulation work where retinol identity, active content, carrier system and supporting documents are specified by the formulator. |
| Rhodiola Extract | Bulk botanical input for nutraceutical capsules, tablets and powders produced under a declared species, plant-part, extraction and marker specification, without a health claim for the finished product. |
| Riboflavin 5'-Phosphate, Sodium | Bulk ingredient for selected nutraceutical and pharmaceutical formulations that require the sodium phosphate derivative rather than free riboflavin or a finished vitamin preparation. |
| Rice Starch | Excipient in selected tablet, capsule and nutraceutical powder systems where the formulation specifies rice starch as a filler, binder or disintegration aid and defines suitable physical and microbiological controls. |
| RNA | Raw material in selected nutraceutical and pharmaceutical formulations that require a defined RNA source, molecular or salt basis and impurity controls. This page makes no health, therapeutic or efficacy claim. |
| Rosmarinic Acid | Nutraceutical and specialty formulators may specify rosmarinic acid powder or a carrier-based preparation by content basis, dosage format, carrier and supporting-document requirements. |
| Royal Jelly | Ingredient for capsules, tablets, sachets and combination supplement formulations where the recipe specifies raw or freeze-dried Royal Jelly of a declared composition, not a finished dosage product. |
| Royal Jelly Powder | Raw material for nutraceutical capsules, tablets, sachets and combination products where the formula names a freeze-dried or spray-dried royal jelly powder of defined composition. |
| Rutin | Rutin powder or declared carrier preparations for nutraceutical and dietary supplement manufacturing, with the formulator setting ingredient identity, assay and excipient requirements. |
| Saccharin | Taste-masking or sweetening ingredient in tablets, powders and selected oral formulations, with grade and chemical form matched to the product specification. |
| Safflower Oil | Refined safflower oil as a formulation vehicle or lipid-base component where the approved product specification defines source, fatty-acid type, quality limits and documentation. Supply is subject to applicable requirements. |
| Sage | Dried botanical raw material for nutraceutical and supplement manufacturers that mill, extract or blend sage under their own finished-product controls, without making health claims for the supplied herb. |
| Salicylic Acid | Intermediate and active-ingredient feedstock for pharmaceutical manufacture, including synthesis routes such as acetylsalicylic acid chemistry and topical preparations, subject to the selected grade and monograph. |
| Salmon Oil | Marine-oil ingredient for nutraceutical softgels, capsules and liquid formulations that name salmon oil and control the fatty-acid profile, oxidation markers, sensory character and supporting documents. |
| Sarcosine | Bulk ingredient evaluation for nutraceutical or pharmaceutical formulation under defined identity and quality controls, without a finished-product health claim. |
| Senna Extract | Bulk botanical ingredient for nutraceutical tablets, capsules and powders manufactured against a written plant-part, extraction and marker specification. |
| Sesame Oil | Lipid carrier and oil-phase ingredient in selected dietary supplements, oral preparations, topical products and ointment bases that specify sesame oil of an appropriate grade. |
| Shea Butter | Fatty base or emollient component in topical creams, ointments and related formulated products when a suitable grade and specification are selected. |
| Shellac | Film-coating, enteric-coating and release-modifying resin in selected tablet, capsule and nutraceutical systems where the grade and performance specification match the formulation. Supply is subject to applicable requirements. |
| Silica Gel | Sachets and bulk desiccant for primary and secondary packaging where product stability depends on a controlled low-humidity environment. |
| Silicone Rubber | Selected tubing, closures and moulded healthcare components when a dedicated grade and the buyer's required quality documentation are stated. |
| Silver Chloride | Electrode material behind disposable ECG, EEG and biosensor sensing pads, where an Ag/AgCl layer provides the stable half-cell. Supply is subject to applicable requirements. |
| Silver Nitrate | Raw material for antimicrobial silver preparations and wound-care formulations when the selected grade and specification permit. Supply is subject to applicable requirements. |
| Simethicone | Active raw material in oral suspensions, chewable or conventional tablets, capsules and other dosage forms that name simethicone in the product specification. Compound and emulsion forms suit different manufacturing routes. |
| Skullcap Extract | Raw material for nutraceutical and herbal supplement formulations that specify a baicalin-standardised skullcap extract. |
| Sodium Alginate | Excipient and film-forming hydrocolloid in oral suspensions, tablet matrices, controlled-release systems and related formulations, subject to the selected pharmaceutical grade and specification. |
| Sodium Ascorbate | Raw material for pharmaceutical and nutraceutical formulations that call for the sodium salt of L-ascorbic acid rather than ascorbic acid or sodium erythorbate. |
| Sodium Benzoate | Specified as a preservative or excipient in selected oral and topical formulations when required by the product specification. |
| Sodium Bicarbonate | Raw material for antacid and effervescent formulations and for dialysis-related manufacturing to an appropriate specification. |
| Sodium Borohydride | Selective reducing agent for pharmaceutical and fine-chemical synthesis, including common aldehyde and ketone reduction steps where NaBH4 is the specified reagent. |
| Sodium Bromide | High-purity grades for pharmaceutical and related formulations subject to the selected monograph, assay and documentation requirements. |
| Sodium Caprylate | Process reagent and formulation input in suitable pharmaceutical and biotechnology production where sodium caprylate is specified by identity and grade. |
| Sodium Cholate | Bile acid salt for pharmaceutical manufacturing where the buyer specifies purity, identity and documentation for the grade. |
| Sodium Citrate | Buffering and pH control in oral and other formulated products; anticoagulant and calcium-binding duty in blood-collection and related preparations when the selected grade meets the required specification. |
| Sodium Copper Chlorophyllin | Colour input for suitable tablet coatings, capsules and oral formulations when the required grade and quality specification are provided. Supply is subject to applicable requirements. |
| Sodium Cyanide | Cyanide reagent for nitrile intermediates in the synthesis of active ingredients. |
| Sodium Cyclamate | Sweetening agent in selected oral syrups, liquids and solid-dose products when the formulation calls for sodium cyclamate against the chosen grade and specification. |
| Sodium Erythorbate | Used to protect oxidation-sensitive ingredients in selected medicinal and related preparations when required by the product specification. |
| Sodium Hypochlorite | Surface and instrument disinfection in clinical and manufacturing hygiene programmes where a hypochlorite solution is selected for the required available chlorine level. |
| Sodium Iodide | Iodide source for cell-culture media, fermentation processes and suitable nutraceutical or pharmaceutical manufacturing without making a finished-product claim. |
| Sodium Lactate | Ingredient for pharmaceutical or electrolyte formulations matched to a stated grade or monograph. This page covers bulk sodium lactate, not finished infusion or clinical dosage products. |
| Sodium Lauryl Sulphate | Tablet disintegrant and wetting agent, and a suspending agent in oral syrups. |
| Sodium Methoxide | Used as a catalyst or intermediate in selected pharmaceutical and vitamin manufacturing routes where sodium methoxide is specified. |
| Sodium Monochloroacetate | Used as a synthesis intermediate where a specified pharmaceutical or fine-chemical route calls for sodium monochloroacetate. |
| Sodium Perborate | Higher-purity grades used in pharmaceutical and oral-hygiene formulation, where purity limits rather than bleaching strength set the specification. |
| Sodium Propionate | Preservative component in pharmaceutical and topical formulation work where a propionate salt rather than the free acid suits the base. |
| Sodium Pyruvate | Raw material for bioprocess, nutraceutical and pharmaceutical manufacture where the grade is qualified against the receiving formulation specification. |
| Sodium Saccharin | Taste-masking sweetener in oral syrups, suspensions, chewable and effervescent tablets, where sodium saccharin is chosen for solubility and stability in the finished formulation. |
| Sodium Salicylate | Used as a pharmaceutical raw material or intermediate when sodium salicylate and the required quality standard are named in the manufacturing specification. |
| Sodium Sarcosinate | Specialty synthesis and process work where sodium sarcosinate is required as the salt rather than free sarcosine. |
| Sodium Starch Glycolate | Superdisintegrant in immediate-release tablets, capsules and granules, drawing liquid into the compact and helping the dosage form break up after administration according to the formulation design. |
| Sodium Stearoyl Lactylate | Emulsifying and processing aid in selected tablet and capsule formulations, subject to the chosen grade and the finished-product specification. |
| Sorbic Acid | Mild preservative or excipient in selected oral and topical preparations when required by the product specification and grade documentation. |
| Sorbitan Laurate | Excipient and emulsifying component in suitable pharmaceutical and healthcare preparations where the required grade and specification are identified. |
| Sorbitan Monopalmitate | Excipient option in suitable topical or other formulations where the required grade identifies sorbitan monopalmitate. |
| Sorbitan Monostearate | Used as an emulsifier in selected topical formulation systems. |
| Sorbitan Sesquioleate | Emulsifying excipient in suitable topical and healthcare formulations where the required specification is identified. |
| Sorbitan Tristearate | Co-emulsifier in selected topical formulation systems when an appropriate grade and supporting specification are required. |
| Sorbitol | Sweetener, vehicle and moisture stabiliser in syrups, oral liquids, soft capsules and selected solid-dose formulations, subject to the selected grade. |
| Soy Isoflavones | Bulk ingredient for nutraceutical, tablet, capsule and powder manufacturing where glycoside or aglycone profile, assay method and carrier dilution are part of the raw-material specification. Finished supplements are separate products. |
| Soy Lecithin | Emulsifying and carrier function in selected pharmaceutical and nutraceutical preparations, subject to the required grade and specification. |
| Soy Protein | Protein ingredient for selected nutrition and formulated products when a suitable food or pharmaceutical-related grade and documentation are specified by the buyer. |
| Span 80 | Emulsifying and dispersing aid in topical and other pharmaceutical formulations when the selected grade and specification are suitable for the dosage form. |
| Spirulina | Raw material for nutraceutical and supplement manufacturers that mill, blend, tablet or encapsulate spirulina under their own finished-product controls, without implying any health efficacy for the biomass itself. |
| Spirulina Powder | Supplement and nutraceutical manufacturers use spirulina powder in tablets, capsules, sachets and bulk blends that specify protein, microbiological and contaminant controls. |
| Stannous Chloride | Reducing agent in radiopharmaceutical preparation kits and comparable formulation work that specifies a tin(II) salt of stated purity. Supply is subject to applicable requirements. |
| Stearyl Alcohol | Waxy excipient and structuring component in selected ointment and topical bases when the quoted grade and documentation match the buyer's requirement. Supply is subject to applicable requirements. |
| Stevia | Sweetening ingredient in selected syrups, chewable products, powders and nutraceutical formulations that specify an appropriate steviol glycoside grade and document set. |
| Stevioside | Sweetness and flavour support in selected nutraceutical powders, oral liquids, chewable formats and related formulations where the exact stevioside grade and document requirements are defined. |
| Strontium Chloride | Raw material considered for suitable nutraceutical or pharmaceutical manufacturing against a complete strontium-salt and hydration specification, without making a finished-product claim. |
| Succinic Acid | Salt formation, intermediate synthesis and formulated pharmaceutical work subject to the selected pharmaceutical grade and specification. |
| Succinic Anhydride | Intermediate in pharmaceutical synthesis routes; grade, purity and documentation requirements should be stated with the enquiry. Supply is subject to applicable requirements. |
| Sucralose | Sweetening agent in selected syrups, chewable tablets and related oral formulations when the buyer specifies a food or formulation grade of sucralose against the required specification. |
| Sucrose | Sweetener, carrier, filler and syrup-base ingredient in selected oral and solid-dose formulations where the quoted grade and documentation match the buyer's excipient specification. Supply is subject to applicable requirements. |
| Sucrose Stearate | Emulsifying, wetting or solubilising excipient in selected topical, liquid and solid formulations where the manufacturer defines the application grade, composition and process-performance requirements. |
| Superoxide Dismutase | Raw enzyme ingredient for capsules, tablets, sachets and other supplement formulations where the recipe specifies SOD source, activity method and complete composition, without a therapeutic or efficacy claim. |
| Synephrine | Raw material for nutraceutical, supplement and specialist formulation under the buyer's identity and finished-product controls, without making health or therapeutic claims for Synephrine. |
| Talc | Tablet lubricant, glidant and selected excipient use when a pharmaceutical grade and documentation set are specified for the formulation. |
| Tartaric Acid | Acidulant or pH-adjusting excipient in selected medicinal and nutraceutical formulations, subject to the required grade, isomer and specification. |
| Tartrazine | Colourant in tablet coatings, capsule shells, syrups and oral liquids when the formulation names this colour index or E number. Supply is subject to applicable requirements. |
| Taurine | Pharmaceutical or nutrition grades support tablets, sachets, medical nutrition and other formulated products where a defined taurine specification and supporting documents are required. |
| Tetrahydrofuran | Reaction medium for pharmaceutical and fine-chemical synthesis, including Grignard and hydride chemistry, subject to the selected purity and stabiliser package. |
| Tetrahydrofurfuryl Alcohol | Used as an intermediate and reaction solvent in pharmaceutical and fine-chemical synthesis. |
| Thaumatin | Taste-system ingredient for selected oral products and nutritional preparations where protein content, carrier, dosage form and supporting documents are specified by the formulator. |
| Theobromine | Bulk input for nutraceutical and specialty formulation work against a written identity and quality specification, without making a finished-product claim. |
| Theophylline | Active ingredient or manufacturing input for pharmaceutical formulations made against the buyer's named quality, impurity and particle-size specification. |
| Thiamine Hydrochloride | Bulk ingredient for nutraceutical and pharmaceutical tablets, capsules and powders made against the buyer's assay, impurity and document requirements. |
| Thionyl Chloride | Process reagent in pharmaceutical and fine-chemical intermediate manufacture where assay, water, related chlorides and residue limits form part of the reaction specification. |
| Thyme | Botanical raw material in selected nutraceutical and pharmaceutical formulations that require a named Thyme species, aerial plant part, physical form and microbiological profile. This page makes no therapeutic claim. |
| Thymol | Pharmaceutical and compounding input for formulations that specify thymol with the required identity, purity and related-substance controls. |
| Tragacanth Gum | Binder, suspending agent and viscosity modifier in pharmaceutical and nutraceutical preparations. |
| Trehalose | Excipient, bulking agent and stabiliser in lyophilised and liquid formulations, including protein and biologics work, where a higher-purity grade is specified. Supply is subject to applicable requirements. |
| Triacetin | Excipient, film-coating plasticiser and solvent in pharmaceutical manufacturing where a pharmacopoeial specification is requested. |
| Tribulus Terrestris Extract | Botanical raw material for nutraceutical tablets, capsules and powdered blends developed to an agreed extract specification. |
| Tricalcium Phosphate | Diluent, flow aid and calcium salt in tablets, capsules and supplement blends, with the granular agglomerate used where direct compression and dust control matter. |
| Trichloroacetic Acid | Reagent or intermediate in controlled pharmaceutical and fine-chemical processing, subject to the required grade and documentation. |
| Triethyl Citrate | Excipient and film-coating plasticiser in pharmaceutical manufacturing when the required grade and specification are stated by the buyer. |
| Triethylamine | Acid scavenger and base catalyst in active ingredient and intermediate synthesis, taking up hydrogen chloride released during acylation, sulphonylation and similar steps. |
| Trimethylamine | Synthesis building block for pharmaceutical and fine-chemical intermediates whose process specification defines TMA form, concentration and impurity limits. |
| Trimethylolpropane Triacrylate | Dental and specialty composite formulations that specify TMPTA as the acrylate monomer. |
| Triphenylphosphine | Used in selected pharmaceutical-intermediate and fine-chemical synthesis routes where the required purity and impurity limits are specified. |
| Tripropylamine | Synthesis base or intermediate in suitable pharmaceutical and fine-chemical routes requiring defined purity. |
| Turmeric | Nutraceutical and supplement manufacturers use turmeric powder and defined extract grades in capsules, tablets and powder blends. Rhizome or extract basis, carrier and finished dosage-form requirements should be stated. |
| Tyrosol | Nutraceutical and formulation-development work where the buyer defines the tyrosol specification and documentation requirement. |
| Uric Acid | Analytical input for pharmaceutical research and quality-control methods where uric acid is the specified analyte or reference. |
| Ursolic Acid | Active botanical compound for nutraceutical development and pharmaceutical research programmes using a defined ursolic acid specification. |
| Valeric Acid | Intermediate for valerate derivatives and selected pharmaceutical synthesis work. |
| Valproic Acid | Active ingredient or controlled process input in pharmaceutical manufacturing programmes that specify valproic acid rather than a valproate salt. |
| Vanillin | Flavour and odour-masking ingredient in suitable oral formulations when a pharmaceutical specification is provided. Supply is subject to applicable requirements. |
| Vanillyl Butyl Ether | Formulation ingredient in selected topical products where the product brief specifically names vanillyl butyl ether. This catalogue page does not assert pain-relief, circulation or other therapeutic efficacy. |
| Vitamin A Palmitate | Nutritional tablets, capsules and controlled supplement formulations using an appropriate solid or oil grade. |
| Vitamin B12 | Raw-material input for supplement, nutraceutical and pharmaceutical manufacturing, supplied as the specifically named B12 form rather than as a generic finished supplement. |
| Vitamin B2 | Used in pharmaceutical and nutraceutical formulations that name riboflavin and require a stated compendial or buyer quality standard. |
| Vitamin B6 | Ingredient for tablets, capsules, sachets and nutraceutical premixes, with assay, particle size and technical documents matched to the finished-product requirement. |
| Vitamin D | Ingredient input for tablet, capsule, soft-gel, powder and liquid supplement manufacture. This page covers bulk vitamin D ingredients, not finished dosage products or consumer-labelled supplements. |
| Vitamin E | Nutritional and formulation use where free tocopherol or alpha-tocopherol is specified as the vitamin E ingredient, subject to the selected grade and buyer specification. |
| Vitamin E Acetate | Softgel, tablet, ointment and topical formulation work that specifies alpha-tocopheryl acetate against a monograph or an in-house specification. |
| Wheat Starch | Binder, filler or disintegrant input for suitable solid-dose formulations when a pharmaceutical grade and full specification are provided. Supply is subject to applicable requirements. |
| Whey Protein | Nutraceutical and healthcare-product formulators specify concentrate, isolate or hydrolysed whey protein for powders and other dosage formats where protein basis, ingredient documents and sensory properties are defined. |
| White Kidney Bean Extract | Botanical raw material for nutraceutical capsules, tablets and powdered supplement blends. |
| White Oil | Excipient, carrier and topical formulation ingredient where the required grade, purity profile and documentation are agreed before supply. |
| Willow Bark Extract | Dietary supplement and nutraceutical raw material where botanical identity, salicin content and documentation are specified by the buyer. |
| Witch Hazel | Botanical ingredient for controlled topical formulation work where Hamamelis virginiana is specified. |
| Xanthan Gum | Specified excipient grades for oral suspensions, tablet binding and controlled-release matrices, subject to the buyer's required specification. |
| Xanthine | Xanthine serves as a starting material and intermediate in the synthesis of methylxanthine pharmaceuticals and as a reference standard in analytical and pharmacological studies. |
| Xylanase | Nutraceutical and digestive-enzyme preparations that specifically identify xylanase and define the activity method, carrier, microbiological limits and required documents without implying a finished-product outcome. |
| Xylitol | Excipient or sweetening component in lozenges, chewable tablets and other formulations made to the buyer's required specification. |
| Yeast | Inactivated S. cerevisiae in selected nutraceutical and supplement formulations that define the biomass composition and quality controls. Strain-specific probiotic cultures require their own identity and viability specification. |
| Yeast Extract | Growth nutrient for selected biotechnology, enzyme and fermentation processes whose media specification identifies a yeast-extract grade and defined quality controls. |
| Zinc Acetate | Zinc raw material for pharmaceutical-development and controlled formulation work where hydrate state, assay and impurity limits are specified by the buyer. |
| Zinc Citrate | Mineral ingredient in selected pharmaceutical and nutraceutical formulations that require a defined zinc citrate grade, zinc content and impurity profile. |
| Zinc Dust | Process reducing agent in intermediate synthesis where the manufacturing specification calls specifically for zinc dust of a defined grade. |
| Zinc Gluconate | Raw material for tablets, capsules, lozenges and liquid formulations that require zinc gluconate with controlled identity, assay, impurities and documentation. Supply is subject to applicable requirements. |
| Zinc Hydroxide | Ingredient for selected topical and pharmaceutical formulations where the buyer specifies the grade and documentation. |
| Zinc Lactate | Ingredient in pharmaceutical and solid-dose formulations that require a documented zinc lactate grade, with hydrate state, purity and impurity controls matched to the approved formula. |
Request a quote
Tell us the product, grade and quantity you need and we will price it.